EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors

Jordan L Bormann, Amy M Kerkvliet

Cutis · 2023

DOI: 10.12788/cutis.0859 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cutis, 2023. Verfasst von Jordan L Bormann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Bormann is from the University of Utah Health Dermatology, Salt Lake City. Dr. Kerkvliet is from the Department of Pathology, Sanford School of M…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Cholangiocarcinoma, Dermatitis, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesCholangiocarcinomaDermatitisMelanomaHumansAntineoplastic Combined Chemotherapy ProtocolsMitogen-Activated Protein Kinase KinasesMutationProtein Kinase InhibitorsProto-Oncogene Proteins B-raf

Substanzen

BRAF protein, humanMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Dr. Bormann is from the University of Utah Health Dermatology, Salt Lake City. Dr. Kerkvliet is from the Department of Pathology, Sanford School of Medicine, University of South Dakota, Sioux Falls.

Zitieren

APA

Bormann, J. L., & Kerkvliet, A. M. (2023). Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors. Cutis. https://doi.org/10.12788/cutis.0859

Vancouver

Bormann JL, Kerkvliet AM. Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors. Cutis. 2023. doi:10.12788/cutis.0859

BibTeX
@article{Bormann2023,
  author = {Bormann, Jordan L and Kerkvliet, Amy M},
  title = {Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors},
  journal = {Cutis},
  year = {2023},
  doi = {10.12788/cutis.0859}
}
Kostenlos starten →